JP2010512169A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512169A5
JP2010512169A5 JP2009541546A JP2009541546A JP2010512169A5 JP 2010512169 A5 JP2010512169 A5 JP 2010512169A5 JP 2009541546 A JP2009541546 A JP 2009541546A JP 2009541546 A JP2009541546 A JP 2009541546A JP 2010512169 A5 JP2010512169 A5 JP 2010512169A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
seq
solvent
nucleoside
coupling solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009541546A
Other languages
English (en)
Japanese (ja)
Other versions
JP5389662B2 (ja
JP2010512169A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/087183 external-priority patent/WO2008073960A2/en
Publication of JP2010512169A publication Critical patent/JP2010512169A/ja
Publication of JP2010512169A5 publication Critical patent/JP2010512169A5/ja
Application granted granted Critical
Publication of JP5389662B2 publication Critical patent/JP5389662B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009541546A 2006-12-12 2007-12-12 高濃度のグアニン・モノマーを含有するオリゴヌクレオチド Active JP5389662B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86958806P 2006-12-12 2006-12-12
US60/869,588 2006-12-12
PCT/US2007/087183 WO2008073960A2 (en) 2006-12-12 2007-12-12 Oligonucleotides containing high concentrations of guanine monomers

Publications (3)

Publication Number Publication Date
JP2010512169A JP2010512169A (ja) 2010-04-22
JP2010512169A5 true JP2010512169A5 (https=) 2011-03-24
JP5389662B2 JP5389662B2 (ja) 2014-01-15

Family

ID=39456527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009541546A Active JP5389662B2 (ja) 2006-12-12 2007-12-12 高濃度のグアニン・モノマーを含有するオリゴヌクレオチド

Country Status (7)

Country Link
US (3) US8586728B2 (https=)
EP (1) EP2125854B1 (https=)
JP (1) JP5389662B2 (https=)
CN (1) CN101611048B (https=)
AU (1) AU2007333147B2 (https=)
CA (1) CA2671873C (https=)
WO (1) WO2008073960A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008063490B4 (de) * 2008-12-17 2023-06-15 Merck Patent Gmbh Organische Elektrolumineszenzvorrichtung und Verfahren zum Einstellen des Farbortes einer weiß emittierenden Elektrolumineszenzvorrichtung
WO2012059510A1 (en) 2010-11-02 2012-05-10 Girindus America, Inc. Back pressure control during solid-phase synthesis on polymeric supports
US10040048B1 (en) 2014-09-25 2018-08-07 Synthego Corporation Automated modular system and method for production of biopolymers
DK3240801T3 (da) 2014-12-31 2021-02-08 Checkmate Pharmaceuticals Inc Kombinationstumorimmunterapi
WO2017005818A1 (en) * 2015-07-08 2017-01-12 Kuros Biosciences Ag Guanine-rich oligonucleotides
JPWO2017111137A1 (ja) 2015-12-22 2018-10-18 味の素株式会社 オリゴヌクレオチドの製造方法
WO2017173334A1 (en) 2016-04-01 2017-10-05 Checkmate Pharmaceuticals, Inc. Fc receptor-mediated drug delivery
US20190076814A1 (en) 2017-09-11 2019-03-14 Synthego Corporation Biopolymer synthesis system and method
CN111246936B (zh) * 2017-10-25 2022-05-03 深圳华大生命科学研究院 用于核酸合成的微流控芯片
US12246031B2 (en) 2018-02-13 2025-03-11 Checkmate Pharmaceuticals, Inc. Compositions and methods for tumor immunotherapy
KR102890791B1 (ko) 2018-04-09 2025-11-24 체크메이트 파마슈티칼스, 인크. 바이러스-유사 입자 내로의 올리고뉴클레오타이드의 포장
EP3850096A1 (en) * 2018-09-11 2021-07-21 Amgen Inc. Purification methods for guanine-rich oligonucleotides
WO2020090822A1 (ja) * 2018-10-30 2020-05-07 東レ株式会社 核酸の非特異結合抑制剤、ハイブリダイゼーション用試薬および核酸のハイブリダイゼーション方法
CN112969527A (zh) * 2018-11-08 2021-06-15 深圳华大生命科学研究院 一种微流控芯片及其制备方法和dna合成方法
EP4047004B1 (en) * 2019-10-18 2024-03-06 FUJIFILM Wako Pure Chemical Corporation Phosphoramidite activator
US20230322842A1 (en) * 2020-04-14 2023-10-12 Sumitomo Chemical Company, Limited Composition containing nucleic acid oligomer
CN114425443B (zh) * 2020-10-29 2025-10-31 江苏金斯瑞生物科技有限公司 一种寡核苷酸合成催化剂
GB202114688D0 (en) 2021-10-14 2021-12-01 Exactmer Ltd Solution phase polymer synthesis
GB202414228D0 (en) 2024-09-27 2024-11-13 Exactmer Ltd Solvent recycling in a liquid-phase process for preparing a defined monomoer sequence polymer

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004749A1 (en) 1983-06-01 1984-12-06 Beckman Instruments Inc Novel preparation of nucleoside phosphoramidite intermediates
US20030050263A1 (en) 1994-07-15 2003-03-13 The University Of Iowa Research Foundation Methods and products for treating HIV infection
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
AU7350798A (en) 1997-04-29 1998-11-24 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
EP0980257A1 (en) 1997-05-01 2000-02-23 Chiron Corporation Use of virus-like particles as adjuvants
US6171591B1 (en) 1997-12-08 2001-01-09 Pentamer Pharmaceuticals, Inc. Recombinant nodavirus compositions and methods
US6541438B1 (en) 1998-05-01 2003-04-01 The Procter & Gamble Company Laundry detergent and/or fabric care compositions comprising a modified cellulase
ATE314095T1 (de) 1998-10-21 2006-01-15 Us Health Virusähnliche partikel zur induktion von autoantikörpern
NZ512456A (en) 1998-11-30 2003-10-31 Cytos Biotechnology Ag Ordered molecular presentation of antigens
EP1165773A4 (en) 1999-02-02 2005-01-05 Biocache Pharmaceuticals Inc IMPROVED PLATFORM FOR PRESENTING ANTIGENS
US8206749B1 (en) 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
SK287400B6 (sk) 1999-09-25 2010-08-09 University Of Iowa Research Foundation Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie
EP1220684B2 (en) 1999-09-27 2010-07-14 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6949520B1 (en) 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
DE60043708D1 (de) 1999-10-13 2010-03-04 Novartis Vaccines & Diagnostic Verfahren zur erhaltung zellimmuneantworten gegen proteinen
ATE290399T1 (de) 1999-11-24 2005-03-15 Chiron Corp Hbv/hcv virus-ohnliche particle
AT409085B (de) 2000-01-28 2002-05-27 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
AU2001239873A1 (en) 2000-02-24 2001-09-03 The Board Of Trustees Of The Leland Stanford Junior University Adjuvant treatment by in vivo activation of dendritic cells
WO2002053141A2 (en) 2000-12-14 2002-07-11 Coley Pharmaceutical Group, Inc. Inhibition of angiogenesis by nucleic acids
US20030050268A1 (en) 2001-03-29 2003-03-13 Krieg Arthur M. Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
AU2002339224B2 (en) 2001-09-14 2008-10-09 Kuros Us Llc Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
JP4360906B2 (ja) 2001-09-14 2009-11-11 サイトス バイオテクノロジー アーゲー ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
US7524950B2 (en) * 2001-10-31 2009-04-28 Agilent Technologies, Inc. Uses of cationic salts for polynucleotide synthesis
CA2488856A1 (en) 2002-06-20 2003-12-31 Cytos Biotechnology Ag Packaged virus-like particles for use as adjuvants: method of preparation and use
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
EP1605972A2 (en) 2003-03-26 2005-12-21 Cytos Biotechnology AG Hiv-peptide-carrier-conjugates
US20060210588A1 (en) 2003-03-26 2006-09-21 Cytos Biotechnology Ag Hiv-peptide-carrier-conjugates
EP1644034B1 (en) 2003-07-10 2011-01-12 Cytos Biotechnology AG Composition for enhancing an immune response comprising packaged virus-like particles
CA2544240A1 (en) * 2003-07-22 2005-02-17 Cytos Biotechnology Ag Cpg-packaged liposomes
JP4628686B2 (ja) * 2004-02-25 2011-02-09 独立行政法人科学技術振興機構 ホスホロアミダイトを含む3’末端ヌクレオシドユニット
CN101076546B (zh) * 2004-09-02 2011-10-26 Isis药物公司 用于低聚物合成的聚合珠
CA2580208A1 (en) 2004-09-21 2006-03-30 Cytos Biotechnology Ag Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide
EP1973608A1 (en) 2005-12-14 2008-10-01 Cytos Biotechnology AG Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity

Similar Documents

Publication Publication Date Title
JP2010512169A5 (https=)
Semenyuk et al. Synthesis of RNA using 2 ‘-O-DTM protection
JP2005518803A5 (https=)
JP2005524393A5 (https=)
JP2005517452A5 (https=)
ATE367441T1 (de) Lipophile derivate doppelsträngiger ribonukleinsäure
JPWO2021055811A5 (https=)
CN109311925A (zh) 立体限定的氧杂氮杂磷杂环戊烷亚磷酰胺单体与核苷或寡核苷酸的增强的偶联
JP6732744B2 (ja) ルテニウム触媒作用によるアゾベンゾール類からのビフェニルアミン類の製造方法
CN101475505A (zh) 甲灭酸的制备方法
CN110590886A (zh) 修饰核苷、核苷酸和核酸聚合物及其制备方法与应用
CN115197289A (zh) 用于测序的核苷酸类似物
JP6920689B2 (ja) 可視光域で光架橋可能な光応答性ヌクレオチドアナログ
JP7298866B2 (ja) 核酸合成用固相担体及びそれを用いた核酸の製造方法
JP2020507346A5 (https=)
JP2008545782A5 (https=)
JP2008541708A (ja) ねじれたインターカレーティング核酸(tina)を用いた、フーグスティーン型の三重鎖および二重鎖の安定でそして選択的な形成、ならびにtinaの調製法
JP2009507478A5 (https=)
JP2008530269A5 (https=)
JP2019137628A (ja) ポリヌクレオチドの連結方法
Jessen et al. Design of an Intercalating Linker Leading to the First Efficiently 5′, 5′‐Linked Alternate‐Strand Hoogsteen Triplex with High Stability and Specificity
JP4665758B2 (ja) チオヌクレオシド−s−ニトロシル誘導体
Kumar et al. C5-alkynyl-functionalized α-L-LNA: Synthesis, thermal denaturation experiments and enzymatic stability
Andersen et al. Nucleic acid secondary structures containing the double-headed nucleoside 5′(S)-C-(2-(thymin-1-yl) ethyl) thymidine
JP2010195698A (ja) オリゴヌクレオチド誘導体、オリゴヌクレオチド誘導体を用いたオリゴヌクレオチド構築物、オリゴヌクレオチド誘導体を合成するための化合物及びオリゴヌクレオチド誘導体の製造方法